Skip to main content
Erschienen in: Reproductive Biology and Endocrinology 1/2021

Open Access 01.12.2021 | Research

Impact of infertility duration on female sexual health

verfasst von: Meng Dong, Xiaoyan Xu, Yining Li, Yixian Wang, Zhuo Jin, Jichun Tan

Erschienen in: Reproductive Biology and Endocrinology | Ausgabe 1/2021

Abstract

Background

Infertility, an important source of stress, could affect sexual life. Extensive studies suggest that the incidence of sexual dysfunction is highly prevalent in infertile women. As the duration of infertility increases, the level of stress is also likely to increase even further, and this could aggravate psychological pain and cause sexual dysfunction. However, the effect of infertility duration on sexual health is unclear.

Methods

We conducted a case-control study in which 715 patients participated between September 1,2020 and December 25, 2020. We included patients diagnosed with infertility (aged between 20 to 45), who were divided into four groups according to their infertility durations: ≤ 2 years (Group I, n = 262), > 2 years but ≤ 5 years (Group II, n = 282), > 5 years but ≤ 8 years (Group III, n = 97), and > 8 years (Group IV, n = 74). A questionnaire survey on female sexual functions and psychological depression was administered to participants, and their female sexual functions and depression status were measured using the Female Sexual Function Index (FSFI) and Patient Health Questionnaire (PHQ-9), respectively.

Results

As the number of years of infertility increased, the PHQ-9 score as well as the incidence of psychological depression increased significantly (p < 0.05), but the total score of FSFI and those of its six domains/sub-scales were not significantly different among the four groups. An analysis of the relevant factors affecting sexual functions, using the multivariable logistic regression model, revealed that when the infertility duration was greater than 8 years, there was a significant increase in the incidence of sexual dysfunction [adjusted odds ratios (AOR) = 5.158, 95% confidence interval (CI): 1.935–13.746, P = 0.001], arousal disorder (AOR = 2.955, 95% CI: 1.194–7.314, P = 0.019), coital pain (AOR = 3.811, 95% CI: 1.045–13.897, P = 0.043), and lubrication disorder (AOR = 5.077, 95% CI: 1.340–19.244, P = 0.017).

Conclusions

An increasing infertility duration is a risk factor for the occurrence of sexual dysfunction. Hence, as the infertility duration increases, the incidence of female sexual dysfunction and psychological distress could also increase, especially when the infertility duration is more than 8 years.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Sexual dysfunction is a global health problem, affecting approximately 41% of premenopausal women [1]. Female sexual dysfunction (FSD), defined as a sexual problem associated with personal distress [2], includes sexual desire disorder, arousal disorder, lubrication difficulties, orgasmic disorder, and pain disorders [3]. It results from the interaction of multiple physical, psychological, relational, and sociocultural factors [4]. In addition, factors, such as age, mental health, income and education levels, lifestyle, race, social background, gender, and endocrine disorders, could affect sexual functions [1, 2, 5].
Infertility is defined as having not been able to conceive after 12 months of unprotected sexual intercourse—specifically referring to penile penetration—in a heterosexual relationship [4], and the duration of the failure to conceive should be ≥ 12 months before an investigation is undertaken [6]. Extensive studies have reported that the diagnosis and treatment of infertility are related to the occurrence of sexual dysfunction [712]. As an important source of stress, infertility can affect the quality of sexual life [13]. Studies reveal that the incidence of sexual dysfunction is greater in infertile women than in those with normal fertility [1417]. Issues such as negative effects of infertility treatment and pressure from family members cause tremendous stress on infertile patients, leading to both psychological and physical pain [12]. Our hypothesis is that as the duration of infertility increases, stress is likely to increase even further, and subsequently, it could aggravate the psychological pain and cause sexual dysfunction.
To the best of our knowledge, only one study has explored the impact of infertility duration on the occurrence of FSD [9]. In this study, 169 infertile women were divided into three groups according to their infertility duration: less than 2 years (Group I), 2–5 years (Group II), and 5 years and longer (Group III). This study found that as the infertility duration extended, the scores of all sexual domains decreased, except sexual satisfaction [9]. However, this study did not include potential confounding factors, and its sample size was relatively small. As far as we know, there is no high-quality study that compares the effects of infertility duration on sexual health. Therefore, our study uses a large sample to explore whether the infertility duration affects female sexual health.

Materials and methods

This is a case-control study which was conducted at the Reproductive Medical Centre of Shengjing Hospital affiliated to China Medical University. A survey of female sexual function and psychological depression of patients with infertility was performed. A total of 715 infertile patients participated in the questionnaire survey between September 1, 2020 and December 25, 2020. Patients with infertility were grouped into four categories according to their infertility duration (defined as the time from these couples’ first attempt to conceive to their entering the study [4]): ≤ 2 years (Group I, n = 262), > 2 years but ≤ 5 years (Group II, n = 282), > 5 years but ≤ 8 years (Group III, n = 97), and > 8 years (Group IV, n = 74).

Study participants

Inclusion criteria: This study’s participants included women who were diagnosed with infertility and younger than 45 years to prevent potential biases, such as age and endocrine environmental factors, given that the incidence of sexual dysfunction increases significantly in perimenopausal women due to a decline in their hormone levels [1, 1823]. This criterion was consistent with the age in previous studies on the sexual functions of women with infertility [4, 9].
Exclusion criteria: Females diagnosed with 1) polycystic ovary syndrome (PCOS), 2) endometriosis, 3) premature ovarian failure, 4) diabetes, 5) high blood pressure, 6) lower genital tract abnormalities, 7) genitourinary infections, 8) genital prolapse, or 9) whose partners had severe male infertility, 10) whose partners had been diagnosed by specialists with sexual dysfunction, 11) presence of psychiatric conditions (that could cause sexual dysfunction), or 12) used drugs that affected sexual functions (e.g., selective serotonin reuptake inhibitors, as well as serotonin and norepinephrine reuptake inhibitors) [8]. We excluded several types of infertilities, such as endometriosis [24], PCOS [25, 26], premature ovarian failure [27, 28], and severe male infertility [2931], that were reported to have affected sexual functions. Taking into account of previous studies, women with a total FSFI score < 8 were excluded because this score implies that they do not have sufficient sexual activity [4, 32, 33]. Participants who did not complete the questionnaire and whose answers were inconsistent (e.g. in questions that focused on sexual functions, “did not attempt intercourse” was selected in one question but not in others) were also excluded.

Applied questionnaires (measurement)

The self-administered questionnaire comprised three parts. The first part was designed to collect information about the sociodemographic characteristics of patients with infertility: age, body mass index (BMI), primary/secondary infertility, smoking status (0=yes, 1=no), economic level, infertility duration, education level(0= ≤ high school, 1=college, 2=undergraduate, 3= ≥postgraduate), drinking alcohol status(1=usually, 2=sometimes, 3=rarely, 4=never), stress in work and life(0=very high, 1=high, 2=general, 3=low, 4=none), and frequency of physical exercise(0=none, 1= <1 time a week, 2=1 time a week, 3= ≥2 times a week).
The second part was a survey of participants' sexual health and sexuality for measuring the FSFI [34] and the four aspects of sexuality, that were adopted from a previous study’s questionnaire [24], including the questions on the importance of sex in general, dyspareunia, the possibility of orgasms in different sexual activities, and the duration of intercourse and foreplay. The importance of sex in general was assessed by asking the following multiple-choice questions: “Is sex important to you?” Response options were set as: very important, important, general, unimportant, and very unimportant. Dyspareunia was assessed by asking “Have you experienced difficulties during sexual intercourse?” Response options were set as: never, very rarely, rarely, sometimes, usually, and almost always. With regard to the possibility of reaching orgasm in different sexual activities, the following three questions were asked: 1. What is the possibility of your reaching orgasm through masturbating? 2. What is the possibility of your reaching orgasm during non-coital intercourse, such as foreplay or oral sex? 3. What is the possibility of your having an orgasm during sexual intercourse? The response options were set as: almost always, always, sometimes, rarely, never, and never tried. The duration of intercourse and foreplay were also evaluated by two questions, whose response options were <1, 1–2, 3–4, 5–7, 8–10, 11–15, 16–30, > 30 minutes and < 1, 2–10, 11–20, 21–30, 31–60, > 60 minutes, respectively. The FSFI includes 19 items and 6 domains of sexual functions (desire, arousal, lubrication, orgasm, satisfaction, and coital pain) based on the sexual status in the preceding 4 weeks [34]. The scores for each domain range from 1.2 to 6 or from 0 to 6, and the total score ranges from 2 to 36, with a Cronbach’s alpha value ≥ 0.82 [20]. The Chinese cut-off of the total FSFI score was ≤ 23.45, which indicated that the women could have sexual dysfunction [35, 36]. The cut-off scores for each domain were established as follows: ≤ 2.7 low desire, ≤ 3.15 arousal disorder, ≤ 4.05 lubrication disorder, ≤ 3.8 orgasm disorder, and ≤ 3.8 sexual pain [36].
The third part was a survey of psychological depression evaluated by Patient Health Questionnaire (PHQ-9) [37]. The items were scored on a 4-point scale from 0 to 3, with a total severity score ranging from 0 to 27. A cut-off score of ≥ 10 was used to assess the presence of depression with a Cronbach’s α value ranging from 0.73 to 0.95 [37].
The study’s participants comprised patients recruited from the Reproductive Medical Centre, who voluntarily participated and to whom anonymous and confidential questionnaires were distributed. They filled them out in a private setting (alone), without any time limit, and the completed questionnaires were placed in a box and collected altogether. The approval for this study was given by the Hospital’s Institutional Review Board for research on human subjects, and the participants were not reimbursed for their involvement.

Statistical analyses

Data analysis was performed using the statistical software SPSS (version 22.0; SPSS Inc., Chicago, IL, USA). Categorical variables were summarised with counts(n) and percentages (%); continuous measures, with counts, means, standard deviations (SDs).
The chi-square test was used to compare the categorical variables and one-way analysis of variance (ANOVA) were used to compare numerical data. Multivariable logistic regression was employed to explore the factors that affect sexual function and each of the five outcomes of desire disorder, arousal disorder, lubrication disorder, orgasm disorder, and coital pain disorder. P value, OR, and 95% CI were evaluated, and a two-tailed p value < 0.05 indicated statistical significance.

Results

Participants’ demographic characteristics

A total of 791 patients participated in this study, and 76 patients were excluded from the study (52 patients failed to complete all the questions, 23 provided inconsistent answers, and 1 had a total FSFI score below 8). Thus, responses of 715 participants were included in the analysis and the response rate was 90.39%. Table 1 summarizes the participants’ demographic characteristics. Of the participants, the average age was 32.68 years (SD, 4.37; range 21-44) and the average infertility duration was 4.08 years (SD, 3.05; range 1-20). There are significant differences in age, BMI, education levels, and physical exercise frequency among the four groups of participants (p < 0.05). There were no significant differences in primary or secondary infertility stress, income levels, or smoking and drinking status among the four groups of participants (p > 0.05) (Table 1).
Table 1
Demographic characteristics of the study participants (n = 715)
Characteristics
Group I (n = 262)
Group II (n = 282)
Group III (n=97)
Group IV (n=74)
P- value
 
Mean ±SD / n (%)
Mean ±SD / n (%)
Mean ±SD / n (%)
Mean ±SD / n (%)
 
Age (years)
31.13 ± 4.36
32.35 ± 3.84
34.25 ± 3.35
37.41 ± 3.59
0.000**
BMI (kg/m2)
23.06 ± 3.27
23.45 ± 3.61
23.49 ± 3.11
25.14 ± 3.04
0.000**
Primary infertility
160 (61.07)
177 (62.77)
58 (59.79)
44 (59.46)
0.683
Secondary infertility
102 (38.93)
105 (37.23)
39 (40.21)
30 (40.54)
 
Smoking status:
    
0.555
 Smoker
13 (5.0)
16 (5.7)
2 (2.1)
4 (5.4)
 
 Non-smoker
249 (95.0)
266 (94.3)
95 (97.9)
70 (94.6)
 
Annual income (ten thousand yuan)
    
0.782
 < 5
127 (48.5)
147 (52.1)
53 (54.6)
38 (51.4)
 
 5-10
80 (30.5)
69 (24.5)
30 (30.9)
24 (32.4)
 
 10-15
30 (11.5)
35 (12.4)
7 (7.2)
5 (6.8)
 
 15-20
13 (5.0)
13 (4.6)
3 (3.1)
3 (4.1)
 
 > 20
12 (4.6)
18 (6.4)
4 (4.1)
4 (5.4)
 
Education
    
0.000**
 ≤ High school
72 (27.5)
93 (33.0)
36 (37.1)
45 (60.8)
 
 College
78 (29.8)
73 (25.9)
20 (20.6)
9 (12.2)
 
 Undergraduate
83 (31.7)
97 (34.4)
37 (38.1)
17 (23.0)
 
 ≥ Postgraduate
29 (11.1)
19 (6.7)
4 (4.1)
3 (4.1)
 
Stress in work and life
    
0.945
 Very high
16 (6.1)
15 (5.3)
3 (3.1)
3 (4.1)
 
 High
48 (18.3)
59 (20.9)
18 (18.6)
15 (20.3)
 
 General
144 (55.0)
146 (51.8)
53 (54.6)
43 (58.1)
 
 Low
37 (14.1)
49 (17.4)
16 (16.5)
9 (12.2)
 
 None
17 (6.5)
13 (4.6)
7 (7.2)
4 (5.4)
 
Physical exercise frequency
    
0.003**
 None
99 (37.8)
91 (32.3)
27 (27.8)
24 (32.4)
 
 < 1 time a week
94 (35.9)
94 (33.3)
24 (24.7)
26 (35.1)
 
 1 time a week
44 (16.8)
40 (14.2)
18 (18.6)
10 (13.5)
 
 ≥ 2 times a week
25 (9.5)
57 (20.2)
28 (28.9)
14 (18.9)
 
Drinking alcohol
    
0.451
 Usually
2 (0.8)
1 (0.4)
1 (1.0)
0 (0)
 
 Sometimes
22 (8.4)
16 (5.7)
7 (7.2)
5 (6.8)
 
 Rarely
106 (40.5)
88 (31.2)
32 (33.0)
29 (39.2)
 
 Never
132 (50.4)
177 (62.8)
57 (58.8)
40 (54.1)
 
Data was described as mean ± SD or n (%)
Abbreviations: SD standard deviation, BMI body mass index
* p < 0.05, ** p < 0.01

Comparison of female psychological and sexual health among patients with different infertility duration

As the number of years of infertility increased, the PHQ-9 score and the incidence of psychological depression increased significantly (p < 0.05). The total FSFI score and those of its six domains were not significantly different among the four groups. Likewise, the incidence of sexual dysfunction, low desire, arousal disorder, lubrication disorder, orgasm disorder, and sexual pain was not significantly different among the four groups (p > 0.05) (Table 2).
Table 2
Female psychological and sexual health among patients with different infertility duration
 
Group I (n = 262)
Group II (n = 282)
Group III (n=97)
Group IV (n=74)
P-value
 
Mean ±SD / n (%)
Mean ±SD / n (%)
Mean ±SD / n (%)
Mean ±SD / n (%)
 
PHQ -9 score
7.01 ± 3.03
7.39 ± 2.98
8.46 ± 2.90
9.39 ± 2.95
0.000**
Incidence of depression
31 (11.8)
49 (17.4)
27 (27.8)
31 (41.9)
0.000**
Sexual life frequency (per month)
5.05 ± 2.88
4.87 ± 2.92
4.66 ± 2.98
4.75 ± 3.25
0.685
FSFI score
27.03 ± 3.86
26.64 ± 3.77
26.48 ± 4.42
26.63 ± 3.59
0.553
Incidence of sexual dysfunction
45 (17.2)
45 (16.0)
20 (20.6)
12 (16.2)
0.765
Sexual desire score
3.46 ± 0.77
3.33 ± 0.69
3.30 ± 0.75
3.24 ± 0.89
0.052
Incidence of low desire
45 (17.2)
58 (20.6)
21 (21.6)
17 (23.0)
0.589
Arousal ability score
4.12 ± 0.96
4.00 ± 0.90
3.93 ± 1.03
3.90 ± 0.92
0.158
Incidence of arousal disorder
41 (15.6)
40 (14.2)
19 (19.6)
13 (17.6)
0.620
Vaginal lubricity score
5.16 ± 0.76
5.14 ± 0.83
5.15 ± 0.86
5.13 ± 0.72
0.995
Incidence of lubrication disorder
25 (9.5)
24 (8.5)
8 (8.2)
5 (6.8)
0.891
Orgasm score
4.60 ± 0.97
4.55 ± 0.96
4.57 ± 0.98
4.55 ± 0.90
0.933
Incidence of orgasm disorder
54 (20.6)
46 (16.3)
22 (22.7)
14 (18.9)
0.454
Satisfaction score
4.73 ± 0.91
4.64 ± 0.94
4.59 ± 1.06
4.60 ± 0.83
0.504
Coital pain score
4.96 ± 0.89
4.97 ± 0.88
4.95 ± 0.97
5.22 ± 0.72
0.143
Incidence of coital pain
28 (10.7)
27 (9.6)
11 (11.3)
4 (5.4)
0.546
Dyspareunia
    
0.092
 Almost always
0 (0.0)
1 (0.4)
2 (2.1)
1 (1.4)
 
 Usually
1 (0.4)
7 (2.5)
3 (3.1)
0 (0.0)
 
 Sometimes
48 (18.3)
46 (16.3)
13 (13.4)
10 (13.5)
 
 Rarely
66 (25.2)
64 (22.7)
24 (24.7)
13 (17.6)
 
 Very rarely
47 (17.9)
56 (19.9)
23 (23.7)
11 (14.9)
 
 Never
100 (38.2)
108 (38.3)
32 (33.0)
39 (52.7)
 
PHQ-9 Patient Health Questionnaire, FSFI Female Sexual Function Index
No significant differences were identified in the frequency of orgasms during different sexual activities and sexual intercourse or foreplay duration in patients with different infertility durations among the four groups (p > 0.05) (Table 3).
Table 3
Importance of sex life, duration of intercourse and foreplay, and frequency of orgasm during different sexual activities
Characteristics
Group I (n = 262)
Group II (n = 282)
Group III (n=97)
Group IV (n=74)
P- value
 
n (%)
n (%)
n (%)
n (%)
 
Importance of sex life
    
0.346
 Very important
12 (4.6)
6 (2.1)
5 (5.2)
1 (1.4)
 
 Important
111 (42.4)
97 (34.4)
35 (36.1)
29 (39.2)
 
 Neutral
127 (48.5)
167 (59.2)
50 (51.5)
40 (54.1)
 
 Unimportant
11 (4.2)
10 (3.5)
7 (7.2)
4 (5.4)
 
 Very unimportant
1 (0.4)
2 (0.7)
0 (0.0)
0 (0.0)
 
Duration of intercourse
    
0.119
 <1min
0 (0.0)
1 (0.4)
1 (1.0)
0 (0.0)
 
 1-2 min
6 (2.3)
7 (2.5)
1 (1.0)
1 (1.4)
 
 3-4 min
30 (11.5)
31 (11.0)
13 (13.4)
14 (18.9)
 
 5-7 min
40 (15.3)
78 (27.7)
21 (21.6)
20 (27.0)
 
 8-10 min
70 (26.7)
64 (22.7)
29 (29.9)
17 (23.0)
 
 11-15 min
57 (21.8)
44 (15.6)
13 (13.4)
11 (14.9)
 
 16-30 min
46 (17.6)
50 (17.7)
17 (17.5)
8 (10.8)
 
 > 30 min
13 (5.0)
7 (2.5)
2 (2.1)
3 (4.1)
 
Duration of foreplay
    
0.595
 <1min
37 (14.1)
47 (16.7)
15 (15.5)
9 (12.2)
 
 2-10 min
181 (69.1)
174 (61.7)
63 (64.9)
52 (70.3)
 
 11-20 min
37 (14.1)
52 (18.4)
15 (15.5)
12 (16.2)
 
 21-30 min
7 (2.7)
6 (2.1)
4 (4.1)
1 (1.4)
 
 31-60 min
0 (0.0)
3 (1.1)
0 (0.0)
0 (0.0)
 
Frequency of orgasm during different sexual activities
Masturbating
    
0.720
 Almost always
36 (13.7)
29 (10.3)
6 (6.2)
6 (8.1)
 
 Usually
26 (9.9)
30 (10.6)
10 (10.3)
8 (10.8)
 
 Sometimes
46 (17.6)
52 (18.4)
18 (18.6)
15 (20.3)
 
 Rarely
36 (13.7)
38 (13.5)
22 (22.7)
12 (16.2)
 
 Never
45 (17.2)
56 (19.9)
13 (13.4)
12 (16.2)
 
 Never tried
73 (27.9)
77 (27.3)
28 (28.9)
21 (28.4))
 
Non-coital activities
    
0.713
 Almost always
15 (5.7)
11 (3.9)
3 (3.1)
3 (4.1)
 
 Usually
26 (9.9)
26 (9.2)
5 (5.2)
7 (9.5)
 
 Sometimes
72 (27.5)
71 (25.2)
24 (24.7)
16 (21.6)
 
 Rarely
57 (21.8)
59 (20.9)
24 (24.7)
18 (24.3)
 
 Never
43 (16.4)
45 (16.0)
14 (14.4)
17 (23.0)
 
 Never tried
49 (18.7)
70 (24.8)
27 (27.8)
13 (17.6)
 
Sexual intercourse
    
0.515
 Almost always
13 (5.0)
10 (3.5)
2 (2.1)
4 (5.4)
 
 Usually
76 (29.0)
74 (26.2)
27 (27.8)
15 (20.3)
 
 Sometimes
104 (39.7)
138 (48.9)
40 (41.2)
37 (50.0)
 
 Rarely
58 (22.1)
47 (16.7)
24 (24.7)
14 (18.9)
 
 Never
10 (3.8)
13 (4.6)
3 (3.1)
4 (5.4)
 
 Never tried
1 (0.4)
0 (0.0)
1 (1.0)
0 (0.0)
 

Multivariable risk factors affecting sexual functions

A multivariable logistic regression model was used to analyze relevant factors— age; BMI; income, education, and stress levels; frequency of sex and physical exercise; smoking and drinking status; and psychological distress—that affect the sexual function.
The results reveal that as the infertility duration increases, the incidence of sexual dysfunction also increases. When infertility duration was greater than 8 years, the values were as follows: low desire (AOR = 1.252, 95% CI: 0.590-2.656, P = 0.558), arousal disorder (AOR = 2.955, 95% CI: 1.194-7.314, P = 0.019), orgasmic disorder (AOR = 2.089, 95% CI: 0.876-4.984, P = 0.097), coital pain (AOR = 3.811, 95% CI: 1.045-13.897, P = 0.043), and lubrication disorder (AOR = 5.077, 95% CI: 1.340-19.244, P = 0.017), and the incidence of sexual dysfunction (AOR = 5.158, 95% CI: 1.935-13.746, P = 0.001). Among them, the incidence of arousal disorder, coital pain, lubrication disorder, and sexual dysfunction significantly increased (p < 0.05). The state of depression was a risk factor for arousal disorder, orgasmic disorder, coital pain, lubrication disorder, and the incidence of sexual dysfunction, but not for sexual desire. Factors significantly and independently associated with low desire were lower frequency of sex and lower education levels. A lower likelihood of arousal disorder was significantly associated with infertility duration of greater than 8 years, increased age, smoking status, and high levels of psychological distress. Orgasmic disorder was significantly associated with BMI and psychological distress. A higher coital pain was significantly associated with infertility duration of greater than 8 years, higher frequency of alcohol consumption, and psychological distress. The risk factors for lubrication disorder were infertility duration of greater than 8 years, lower frequency of sexual life, high stress levels, and psychological distress. A higher likelihood of sexual dysfunction was observed in patients with increasing infertility duration, increasing age, lower frequency of sexual life, and high levels of psychological distress (Table 4).
Table 4
Factors associated with sexual dysfunction, multivariable-adjusted odds ratios and 95% confidence intervals
Independent variable
Low desire
Arousal disorder
Orgasmic disorder
Coital pain
Lubrication disorder
Sexual dysfunction
Infertility duration
 ≤ 2 years
1.000
1.000
1.000
1.000
1.000
1.000
 2-5 years
1.299 (0.594-2.843)
P=0.512
2.187 (0.884-5.412)
P=0.090
1.624 (0.682-3.872)
P=0.274
2.972 (0.810-10.903)
P=0.100
2.067 (0.540-7.916)
P=0.289
2.995 (1.137-7.891)
P=0.026*
 5-8 years
1.410 (0.698-2.851)
P=0.338
2.029 (0.858-4.798)
P=0.107
1.318 (0.574-3.026)
P=0.514
3.198 (0.924-11.065)
P=0.066
3.365 (0.950-11.917)
P=0.060
3.553 (1.410-8.955)
P=0.007**
 > 8 years
1.252 (0.590-2.656)
P=0.558
2.955 (1.194-7.314)
P=0.019*
2.089 (0.876-4.984)
P=0.097
3.811 (1.045-13.897)
P=0.043*
5.077 (1.340-19.244)
P=0.017*
5.158 (1.935-13.746)
P=0.001**
Age (years)
1.048 (0.997-1.102)
P=0.065
1.096 (1.033-1.162)
P=0.002**
1.013 (0.958-1.072)
P=0.643
1.005 (0.936-1.080)
P=0.886
1.034 (0.957-1.117)
P=0.399
1.093 (1.029-1.161)
P=0.004**
Body mass index
1.009 (0.953-1.068)
P=0.753
0.959 (0.894-1.028)
P=0.241
0.927 (0.868-0.991)
P=0.025*
1.029 (0.951-1.115)
P=0.474
1.004 (0.918-1.098)
P=0.932
1.019 (0.952-1.092)
P=0.582
Income level
1.019 (0.857-1.212)
P=0.828
0.937 (0.762-1.154)
P=0.542
1.031 (0.855-1.244)
P=0.746
0.903 (0.704-1.158)
P=0.423
0.823 (0.619-1.096)
P=0.182
0.852 (0.683-1.061)
P=0.153
Sexual life frequency (per month)
0.890 (0.822-0.963)
P=0.004**
0.911 (0.829-1.000)
P=0.051
0.938 (0.863-1.020)
P=0.134
0.946 (0.850-1.052)
P=0.304
0.791(0.688-0.909)
P=0.001**
0.888 (0.805-0.981)
P=0.019*
Education level
0.780 (0.629-0.967)
P=0.024*
0.993 (0.779-1.265)
P=0.952
1.121 (0.894-1.405)
P=0.322
1.213 (0.906-1.624)
P=0.195
0.969 (0.704-1.333)
P=0.847
1.193 (0.934-1.523)
P=0.158
Stress level
1.021 (0.819-1.273)
P=0.853
0.935 (0.729-1.198) 
P=0.595
0.890 (0.700-1.131)
P=0.340
1.004 (0.740-1.362)
P=0.981
0.700 (0.501-0.977)
P=0.036*
0.774 (0.596-1.005)
P=0.054
Physical exercise frequency
0.839 (0.696-1.011)
P=0.066
0.885 (0.715-1.095) 
P=0.260
0.892 (0.730-1.090)
P=0.264
0.960 (0.744-1.237)
P=0.750
1.146 (0.871-1.508)
P=0.329
0.870 (0.701-1.081)
P=0.209
Smoking status
0.654 (0.297-1.442)
P=0.293
0.406 (0.168-0.980)
P=0.045*
1.410 (0.474-4.196)
P=0.537
3.210 (0.613-16.808)
P=0.167
1.823 (0.421-7.890)
P=0.422
0.728 (0.267-1.984)
P=0.535
Drinking status
1.082 (0.803-1.459)
P=0.604
1.283 (0.899-1.829)
P=0.169
0.957 (0.692-1.325)
P=0.792
0.597 (0.407-0.876)
P=0.008**
0.834 (0.541-1.283)
P=0.408
1.056 (0.741-1.504)
P=0.765
Psychological distress
1.059 (0.996-1.126)
P=0.065
1.317 (1.224-1.416)
P=0.000**
1.351 (1.252-1.458)
P=0.000**
1.246 (1.157-1.342)
P=0.000**
1.320 (1.219-1.429)
P=0.000**
1.464 (1.344-1.596)
P=0.000**
* p < 0.05, ** p < 0.01

Discussion

In this large-scale case-control study, we have reported the impact of infertility duration on the FSD of patients with infertility and analyzed the risk factors that affect their sexual health. The multivariate logistic regression model revealed that an increasing infertility duration is a risk factor for the occurrence of sexual dysfunction.
According to our literature review, only one clinical study [9] investigated the impact of infertility duration on FSD. It found that sexual dysfunction, including low desire, arousal disorder, orgasm disorder, coital pain, and lubrication disorder were significantly higher in the > 5 years group, as compared with the < 2 years and 2–5 years infertility duration groups [9]. However, this study did not include interferences of potential confounding factors that would affect sexual functions, such as age, BMI, income level, education level, smoking, and drinking status. Moreover, it did not indicate the exclusion criteria, and its sample size was relatively small. Thus, we believe the conclusions drawn from this study have substantial limitations.
In another study on the impact of infertility-related distress on female sexual functions, infertility duration as a variable of infertility-related factors and hierarchical binary logistic regression showed that infertility-related factors (infertility duration) were insignificantly associated with sexual functions [4]. The study also compared the infertility duration of infertile patients with and without sexual dysfunction, which were 5.4 ± 3.4 versus 5.9 ± 3.9, respectively, and found no significant difference [4]. Its research purpose, inclusion and exclusion criteria, and method were all different from ours, thus possibly explaining the difference in results.
Another study conducted in Turkey (including 352 infertile and 301 normal fertility women) aimed to evaluate the prevalence and risk factors for sexual dysfunction in females with infertility. The results of multivariate logistic regression showed that a > 3 years duration of both marriage and infertility, together with a history of previous infertility treatment were risk factors for sexual dysfunction [7]. This study’s conclusion is partially consistent with ours, but it did not further divide the infertility duration. In our study, we identified that an infertility duration > 8 years was a risk factor for arousal, pain, lubrication disorder, and sexual dysfunction, but not for desire and orgasmic dysfunction.
Infertile patients undergoing assisted reproduction often report sexual disorders, especially in terms of decreased interest and desire for sex, poorer arousal and lubrication, and orgasm difficulties [12, 38, 39]. A study found that sexual desire disorder occurs differently in women of different ages, and the prevalence of this diagnosis is reported at 8.9% in 18–44-year-olds, 12.3% in 45–64-year-olds, and 7.4% in the age group > 65 years [40]. In our study, the loss of sexual desire increased as the years of infertility increased (an average of 17.2% increased to 23.0%), but there was no significant difference. The high incidence rate of low sexual desire was probably owing to the following reasons: when women with infertility realize that normal sexual intercourse does not lead to pregnancy, they may lose their desire for sex. Moreover, sexual intercourse for the sake of childbirth, rather than simply for pleasure, may also inhibit the occurrence of sexual desire.
This study also found that an infertility duration of greater than 8 years is a risk factor for sexual arousal disorder, that is also related to age, depression, and smoking in our study. Previous research found that unhappy life events, psychosocial distress, drug use, gynecological disorders, and disruptions to hormone production could precipitate sexual arousal disorder [18]. Other studies also believe that smoking increases the incidence of sexual dysfunction [4143].
A few studies have reported the possibility of infertile patients achieving orgasms during different sexual activities, which may be closely related to sexual satisfaction [24]. However, our study did not identify differences in sexual satisfaction among patients with different infertility durations, or find possible differences in their orgasms during different sexual activities. Therefore, we believe that the infertility duration did not have a significant effect on the orgasm function. Conversely, we noted that during different sexual activities, the possibility of patients with infertility achieving orgasms always or often is less than 30%, which is much lower than that reported for those with normal fertility [24]. This may be because sexual intercourse is purposeful (fertility) rather than out of instinct and pleasure.
The duration of sexual intercourse mainly affects the possibility of orgasm dysfunction. Researchers believe that the likelihood or consistency of partnered orgasm among women is associated with the duration of penile-vaginal intercourse, but not with that of foreplay [44]. An extremely short foreplay duration could indicate that the partner has insufficient emotional intimacy during sex, whereas an extremely long foreplay duration could indicate intercourse difficulties, which could also affect sexual satisfaction. In our group, we did not identify any difference between either. Hence, it can be seen that the infertility duration has a minimal effect on orgasm function or sexual satisfaction.
In this study, we observed that the PHQ-9 score increases significantly with the increase in infertility duration. When we conducted multivariate regression analysis with depressive status as a potential confounding factor, we observed that depression was a risk factor for sexual dysfunction, except for sexual desire. Therefore, it can be speculated that the increase in the infertility duration increases the incidence of sexual dysfunction by affecting these women psychologically and emotionally. Many studies have reported the impact of psychological depression on sexual functions in patients with infertility [4, 12, 45]. With the increase of infertility duration, infertility-related stress also gradually increases, which in turn affects the mental health of infertile patients [46]. Research comparisons have found that infertility for more than 3 years significantly increases anxiety and depressed moods, and decreases the quality of life of patients with infertility [46]. Decreased sexual function will seriously affect the quality of life and damage mental health. Conversely, a depressed mental state could also increase the incidence of sexual dysfunction [7].
The cause of FSD is complex and multifactorial. A new study reviews its common etiologies and risk factors—age and menopausal status, psychiatric conditions (anxiety and depression), medical conditions (diabetes, hypertension, neurologic disease, premature ovarian failure, and gynecologic diseases), stress (emotional or environmental), medications (psychotropic medications, antihypertensives, histamine blockers, and hormonal medications), relationship and lifestyle—that may play a role [2]. To increase the reliability of our study’s results, some above-mentioned causes and risk factors were excluded. Furthermore, factors such as stress (emotional or environmental), relationships, and lifestyle that were difficult to evaluate were not discussed in our study, and hence, not included in our exclusion criteria, which could be a limitation.
This study also has some other limitations. First, limitations arise from its strict exclusion criteria. Second, we made assumptions relating to heterosexuality, given that sexual orientation information was not collected from the participants. Moreover, because ours was a retrospective study, a large sample of multi-center experiments is required to further confirm its conclusions.

Conclusions

As the infertility duration increases, the incidence of FSD and psychological distress may increase, especially when the infertility duration is more than 8 years. When treating infertility, especially in patients who have been infertile for a long time, reproductive doctors should also pay attention to the evaluation of their sexual health. The psychological stress caused by prolonged infertility may lead to the occurrence of sexual dysfunction, which in turn, further increases psychological distress. Attention should be paid to such patients’ sexual and mental health, so that reproductive doctors can better evaluate and manage infertile women’s sexual problems.

Acknowledgement

Great thanks would go to Mr. Xingchao Li and Editage for their language polishing of this article.

Code availability

Not applicable.

Declarations

This study was approved by the Shengjing Hospital Institutional Review Board for Research on Human Subjects (2020PS009F).
This is a secondary data analysis of a cross-sectional study. The data are anonymous, and the requirement for informed consent was therefore waived.
All the authors in this paper consent to publication of the work.

Competing interests

All authors have no conflicts of interest to declare.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat McCool Megan E, Andrea Z, Theurich Melissa A, et al. Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies. Sex Med Rev. 2016;4:197–212.PubMedCrossRef McCool Megan E, Andrea Z, Theurich Melissa A, et al. Prevalence of Female Sexual Dysfunction Among Premenopausal Women: A Systematic Review and Meta-Analysis of Observational Studies. Sex Med Rev. 2016;4:197–212.PubMedCrossRef
2.
Zurück zum Zitat Wheeler Lindsay J, Guntupalli Saketh R. Female Sexual Dysfunction: Pharmacologic and Therapeutic Interventions. Obstet Gynecol. 2020;136:174–86.PubMedCrossRef Wheeler Lindsay J, Guntupalli Saketh R. Female Sexual Dysfunction: Pharmacologic and Therapeutic Interventions. Obstet Gynecol. 2020;136:174–86.PubMedCrossRef
3.
Zurück zum Zitat American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association; 2000. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association; 2000.
4.
Zurück zum Zitat Federica F, Edgardo S, Andrea B, et al. Infertility-related distress and female sexual function during assisted reproduction. Hum Reprod. 2019;34:1065–73.CrossRef Federica F, Edgardo S, Andrea B, et al. Infertility-related distress and female sexual function during assisted reproduction. Hum Reprod. 2019;34:1065–73.CrossRef
5.
Zurück zum Zitat Shalender B, Paul E, Andrea C, et al. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–611.CrossRef Shalender B, Paul E, Andrea C, et al. Sexual dysfunction in men and women with endocrine disorders. Lancet. 2007;369:597–611.CrossRef
6.
Zurück zum Zitat American Society for Reproductive Medicine, Birmingham, Alabama. Practice Committee of the American Society for Reproductive Medicine, Definition of "infertility". Fertil Steril. 2006;86:S228. American Society for Reproductive Medicine, Birmingham, Alabama. Practice Committee of the American Society for Reproductive Medicine, Definition of "infertility". Fertil Steril. 2006;86:S228.
7.
Zurück zum Zitat Volkan T, Aycan K, Aykut O, et al. Sexual dysfunction in infertile Turkish females: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol. 2014;182:128–31.CrossRef Volkan T, Aycan K, Aykut O, et al. Sexual dysfunction in infertile Turkish females: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol. 2014;182:128–31.CrossRef
8.
Zurück zum Zitat Keskin U, Coksuer H, Gungor S, Ercan CM, Karasahin KE, Baser I. Differences in prevalence of sexual dysfunction between primary and secondary infertile women. Fertil Steril. 2011;96:1213–7.PubMedCrossRef Keskin U, Coksuer H, Gungor S, Ercan CM, Karasahin KE, Baser I. Differences in prevalence of sexual dysfunction between primary and secondary infertile women. Fertil Steril. 2011;96:1213–7.PubMedCrossRef
9.
Zurück zum Zitat Asli I, Demet AK, Eftal TC. Effects of infertility and infertility duration on female sexual functions. Arch Gynecol Obstet. 2013;287:809–12.CrossRef Asli I, Demet AK, Eftal TC. Effects of infertility and infertility duration on female sexual functions. Arch Gynecol Obstet. 2013;287:809–12.CrossRef
10.
Zurück zum Zitat Davari Tanha F, Mohseni M, Ghajarzadeh M. Sexual function in women with primary and secondary infertility in comparison with controls. Int J Impot Res. 2014;26:132–4.PubMedCrossRef Davari Tanha F, Mohseni M, Ghajarzadeh M. Sexual function in women with primary and secondary infertility in comparison with controls. Int J Impot Res. 2014;26:132–4.PubMedCrossRef
11.
Zurück zum Zitat Winkelman WD, Katz PP, Smith JF, Rowen TS, Infertility Outcomes Program Project Group. The sexual impact of infertility among women seeking fertility care. Sex Med. 2016;4:e190–7.PubMedPubMedCentralCrossRef Winkelman WD, Katz PP, Smith JF, Rowen TS, Infertility Outcomes Program Project Group. The sexual impact of infertility among women seeking fertility care. Sex Med. 2016;4:e190–7.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Nelson Christian J, Shindel Alan W, Naughton Cathy K, et al. Prevalence and predictors of sexual problems, relationship stress, and depression in female partners of infertile couples. J Sex Med. 2008;5:1907–14.PubMedCrossRef Nelson Christian J, Shindel Alan W, Naughton Cathy K, et al. Prevalence and predictors of sexual problems, relationship stress, and depression in female partners of infertile couples. J Sex Med. 2008;5:1907–14.PubMedCrossRef
13.
Zurück zum Zitat Jane R. Sexual problems associated with infertility, pregnancy, and ageing. BMJ. 2004;329:559–61.CrossRef Jane R. Sexual problems associated with infertility, pregnancy, and ageing. BMJ. 2004;329:559–61.CrossRef
14.
Zurück zum Zitat Khademi A, Alleyassin A, Amini M, Ghaemi M. Evaluation of sexual dysfunction prevalence in infertile couples. J Sex Med. 2008;5:1402–10.PubMedCrossRef Khademi A, Alleyassin A, Amini M, Ghaemi M. Evaluation of sexual dysfunction prevalence in infertile couples. J Sex Med. 2008;5:1402–10.PubMedCrossRef
15.
Zurück zum Zitat Millheiser LS, Helmer AE, Quintero RB, Westphal LM, Milki AA, Lathi RB. Is infertility a risk factor for female sexual dysfunction? A case-control study. Fertil Steril. 2010;94:2022–5.PubMedCrossRef Millheiser LS, Helmer AE, Quintero RB, Westphal LM, Milki AA, Lathi RB. Is infertility a risk factor for female sexual dysfunction? A case-control study. Fertil Steril. 2010;94:2022–5.PubMedCrossRef
16.
Zurück zum Zitat Gabr AA, Omran EF, Abdallah AA, Kotb MM, Farid EZ, Dieb AS, et al. Prevalence of sexual dysfunction in infertile versus fertile couples. Eur J Obstet Gynecol Reprod Biol. 2017;217:38–43.PubMedCrossRef Gabr AA, Omran EF, Abdallah AA, Kotb MM, Farid EZ, Dieb AS, et al. Prevalence of sexual dysfunction in infertile versus fertile couples. Eur J Obstet Gynecol Reprod Biol. 2017;217:38–43.PubMedCrossRef
17.
Zurück zum Zitat Mirblouk F, Asgharnia DM, Solimani R, Fakor F, Salamat F, Mansoori S. Comparison of sexual dysfunction in women with infertility and without infertility referred to Al-Zahra Hospital in 2013–2014. Int J Reprod Biomed (Yazd). 2016;14:117–24.CrossRef Mirblouk F, Asgharnia DM, Solimani R, Fakor F, Salamat F, Mansoori S. Comparison of sexual dysfunction in women with infertility and without infertility referred to Al-Zahra Hospital in 2013–2014. Int J Reprod Biomed (Yazd). 2016;14:117–24.CrossRef
19.
Zurück zum Zitat Worsley R, Bell RJ, Gartoulla P, Davis SR. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women. J Sex Med. 2017;14:675–86.PubMedCrossRef Worsley R, Bell RJ, Gartoulla P, Davis SR. Prevalence and predictors of low sexual desire, sexually related personal distress, and hypoactive sexual desire dysfunction in a community-based sample of midlife women. J Sex Med. 2017;14:675–86.PubMedCrossRef
20.
Zurück zum Zitat Zeleke BM, Bell RJ, Billah B, Davis SR. Hypoactive sexual desire dysfunction in community-dwelling older women. Menopause. 2017;24:391–9.PubMedCrossRef Zeleke BM, Bell RJ, Billah B, Davis SR. Hypoactive sexual desire dysfunction in community-dwelling older women. Menopause. 2017;24:391–9.PubMedCrossRef
21.
Zurück zum Zitat Nastri Carolina O, Lara Lucia A, Ferriani Rui A, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013;6:CD009672. Nastri Carolina O, Lara Lucia A, Ferriani Rui A, et al. Hormone therapy for sexual function in perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2013;6:CD009672.
22.
Zurück zum Zitat Scheffers Carola S, Armstrong Sarah,Cantineau Astrid E P et al. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015;1:CD011066. Scheffers Carola S, Armstrong Sarah,Cantineau Astrid E P et al. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015;1:CD011066.
23.
Zurück zum Zitat Caio L, Valadares Ana LR, Baccaro Luiz F, et al. Is the age at menopause a cause of sexual dysfunction? A Brazilian population-based study. Menopause. 2018;25:70–6.CrossRef Caio L, Valadares Ana LR, Baccaro Luiz F, et al. Is the age at menopause a cause of sexual dysfunction? A Brazilian population-based study. Menopause. 2018;25:70–6.CrossRef
24.
Zurück zum Zitat Silvan H, Alexandra K-S, Patrick I, et al. Sexual Satisfaction and Frequency of Orgasm in Women With Chronic Pelvic Pain due to Endometriosis. J Sex Med. 2020;17:2417–26.CrossRef Silvan H, Alexandra K-S, Patrick I, et al. Sexual Satisfaction and Frequency of Orgasm in Women With Chronic Pelvic Pain due to Endometriosis. J Sex Med. 2020;17:2417–26.CrossRef
25.
Zurück zum Zitat Fatemeh B, Saeide Z, Ali M, et al. Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach. Fertil Steril. 2013;100:1389–96.CrossRef Fatemeh B, Saeide Z, Ali M, et al. Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach. Fertil Steril. 2013;100:1389–96.CrossRef
26.
Zurück zum Zitat Marissa SW, Hsu RA, Allison Kelly C, et al. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome. Fertil Steril. 2021;115:474–82.CrossRef Marissa SW, Hsu RA, Allison Kelly C, et al. Lifestyle modifications alone or combined with hormonal contraceptives improve sexual dysfunction in women with polycystic ovary syndrome. Fertil Steril. 2021;115:474–82.CrossRef
27.
Zurück zum Zitat Schover LR. Premature ovarian failure is a major risk factor for cancer-related sexual dysfunction. Cancer. 2014;120:2230–2.PubMedCrossRef Schover LR. Premature ovarian failure is a major risk factor for cancer-related sexual dysfunction. Cancer. 2014;120:2230–2.PubMedCrossRef
28.
Zurück zum Zitat Laguna B-PC, Magda SP, Donovan GHP, et al. Role of the different sexuality domains on the sexual function of women with premature ovarian failure. J Sex Med. 2015;12:685–9.CrossRef Laguna B-PC, Magda SP, Donovan GHP, et al. Role of the different sexuality domains on the sexual function of women with premature ovarian failure. J Sex Med. 2015;12:685–9.CrossRef
29.
Zurück zum Zitat Bechoua S, Hamamah S, Scalici E. Male infertility: an obstacle to sexuality? Andrology. 2016;4:395–403.PubMedCrossRef Bechoua S, Hamamah S, Scalici E. Male infertility: an obstacle to sexuality? Andrology. 2016;4:395–403.PubMedCrossRef
30.
Zurück zum Zitat Lotti F, Corona G, Castellini G, et al. Semen quality impairment is associated with sexual dysfunction according to its severity. Hum Reprod. 2016;31:2668–80.PubMedCrossRef Lotti F, Corona G, Castellini G, et al. Semen quality impairment is associated with sexual dysfunction according to its severity. Hum Reprod. 2016;31:2668–80.PubMedCrossRef
31.
Zurück zum Zitat Lotti F, Corona G, Rastrelli G, Forti G, Jannini EA, Maggi M. Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. J Sex Med. 2012;9:2698–707.PubMedCrossRef Lotti F, Corona G, Rastrelli G, Forti G, Jannini EA, Maggi M. Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. J Sex Med. 2012;9:2698–707.PubMedCrossRef
32.
Zurück zum Zitat Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118:4606–18.PubMedCrossRef Baser RE, Li Y, Carter J. Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors. Cancer. 2012;118:4606–18.PubMedCrossRef
33.
Zurück zum Zitat Hevesi K, Mészáros V, Kövi Z, Márki G, Szabó M. Different characteristics of the Female Sexual Function Index in a sample of sexually active and inactive women. J Sex Med. 2017;14:1133–41.PubMedCrossRef Hevesi K, Mészáros V, Kövi Z, Márki G, Szabó M. Different characteristics of the Female Sexual Function Index in a sample of sexually active and inactive women. J Sex Med. 2017;14:1133–41.PubMedCrossRef
34.
Zurück zum Zitat Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.PubMedCrossRef Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26(2):191–208.PubMedCrossRef
35.
Zurück zum Zitat Seen-Tsing LS, Wai-Ming K. Prevalence and Risk Factors for Sexual Problems and Distress in Chinese Unmarried Young Women: An Observational Study. J Sex Med. 2018;15:1620–8.CrossRef Seen-Tsing LS, Wai-Ming K. Prevalence and Risk Factors for Sexual Problems and Distress in Chinese Unmarried Young Women: An Observational Study. J Sex Med. 2018;15:1620–8.CrossRef
36.
Zurück zum Zitat Ma J, Pan L, Yu L, et al. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study. J Sex Med. 2014;11:909–19.PubMedCrossRef Ma J, Pan L, Yu L, et al. Prevalence of female sexual dysfunction in urban chinese women based on cutoff scores of the Chinese version of the female sexual function index: a preliminary study. J Sex Med. 2014;11:909–19.PubMedCrossRef
38.
Zurück zum Zitat Smith NK, Madeira J, Millard HR. Sexual function and fertility quality of life in women using in vitro fertilization. J Sex Med. 2015;12:985–93.PubMedCrossRef Smith NK, Madeira J, Millard HR. Sexual function and fertility quality of life in women using in vitro fertilization. J Sex Med. 2015;12:985–93.PubMedCrossRef
39.
Zurück zum Zitat Coralie P-L, Audrey B, Belina C-M, et al. Attachment and sexual functioning in women and men seeking fertility treatment. J Psychosom Obstet Gynaecol. 2019;40:202–10.CrossRef Coralie P-L, Audrey B, Belina C-M, et al. Attachment and sexual functioning in women and men seeking fertility treatment. J Psychosom Obstet Gynaecol. 2019;40:202–10.CrossRef
40.
Zurück zum Zitat Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–8.PubMedCrossRef Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–8.PubMedCrossRef
41.
Zurück zum Zitat Christensen Birgitte S, Morten G, Pedersen Bo V, et al. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med. 2011;8:1903–16.PubMedCrossRef Christensen Birgitte S, Morten G, Pedersen Bo V, et al. Associations of unhealthy lifestyle factors with sexual inactivity and sexual dysfunctions in Denmark. J Sex Med. 2011;8:1903–16.PubMedCrossRef
42.
Zurück zum Zitat Ming WL, Chris R, Cheng Y, et al. Tobacco smoking and sexual difficulties among Australian adults: a cross-sectional study. Sex Health. 2017;14:313–9.CrossRef Ming WL, Chris R, Cheng Y, et al. Tobacco smoking and sexual difficulties among Australian adults: a cross-sectional study. Sex Health. 2017;14:313–9.CrossRef
43.
Zurück zum Zitat Wallwiener Christian W, Lisa-Maria W, Harald S, et al. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med. 2010;7:2139–48.PubMedCrossRef Wallwiener Christian W, Lisa-Maria W, Harald S, et al. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med. 2010;7:2139–48.PubMedCrossRef
44.
Zurück zum Zitat Petr W, Stuart B. Women's partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplay. J Sex Med. 2009;6:135–41.CrossRef Petr W, Stuart B. Women's partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplay. J Sex Med. 2009;6:135–41.CrossRef
45.
Zurück zum Zitat Zahra S, Davari TF, Mahsa G. Depression, sexual dysfunction and sexual quality of life in women with infertility. BMC Womens Health. 2018;18:92.CrossRef Zahra S, Davari TF, Mahsa G. Depression, sexual dysfunction and sexual quality of life in women with infertility. BMC Womens Health. 2018;18:92.CrossRef
46.
Zurück zum Zitat Clelia ZM, Francesca CDVM, Federica V. Predictors of quality of life and psychological health in infertile couples: the moderating role of duration of infertility. Qual Life Res. 2018;27:945–54.CrossRef Clelia ZM, Francesca CDVM, Federica V. Predictors of quality of life and psychological health in infertile couples: the moderating role of duration of infertility. Qual Life Res. 2018;27:945–54.CrossRef
Metadaten
Titel
Impact of infertility duration on female sexual health
verfasst von
Meng Dong
Xiaoyan Xu
Yining Li
Yixian Wang
Zhuo Jin
Jichun Tan
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Reproductive Biology and Endocrinology / Ausgabe 1/2021
Elektronische ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-021-00837-7

Weitere Artikel der Ausgabe 1/2021

Reproductive Biology and Endocrinology 1/2021 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.